EXTERNAL DRAINAGE OF SUBRETINAL FLUID DURING RHEGMATOGENOUS RETINAL DETACHMENT REPAIR.
| Autor: | Belin PJ; VitreoRetinal Surgery, PA, Minneapolis, Minnesota., Mundae R; Department of Ophthalmology, University of Minnesota, Minneapolis, Minnesota; and., Tzu JH; Retina and Vitreous of Texas, Houston, Texas., Chang E; Retina and Vitreous of Texas, Houston, Texas., Parke DW 3rd; VitreoRetinal Surgery, PA, Minneapolis, Minnesota. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Retina (Philadelphia, Pa.) [Retina] 2021 Sep 01; Vol. 41 (9), pp. 1828-1832. |
| DOI: | 10.1097/IAE.0000000000003136 |
| Abstrakt: | Purpose: To describe the safety and efficacy of rhegmatogenous retinal detachment (RRD) repair with external drainage of subretinal fluid using a 28-gauge External Drainage and Depression device (Vortex Surgical, Chesterfield, MO). Methods: Retrospective review of patients who underwent primary rhegmatogenous retinal detachment repair with scleral buckle, pars plana vitrectomy, or scleral buckle/pars plana vitrectomy using the drainage device from August 2018 through March 2020, performed by four surgeons at two vitreoretinal practices. Results: Eighty-three eyes of 83 patients were included. At presentation, 28% had proliferative vitreoretinopathy. Surgery included 65% scleral buckle/pars plana vitrectomy, 33% pars plana vitrectomy, and 2% scleral buckle. There were no cases of retinal incarceration and two subretinal hemorrhages at the drainage site (both < 2 DD), 2 cases of recurrent RD with proliferative vitreoretinopathy (1 had proliferative vitreoretinopathy at presentation), and 6 (10%) new epiretinal membranes (3 were mild). There were no other complications. Mean follow-up was 274 days. Single operation success rate for those with ≥ 6-month follow-up was 97% (57/59). Conclusion: External drainage of subretinal fluid during rhegmatogenous retinal detachment repair demonstrated a favorable safety profile with a high single operation success rate. Further study of the role of external drainage in rhegmatogenous retinal detachment repair is warranted. Competing Interests: D. W. Parke and E. Chang receive royalties from Vortex Surgical for their patent on the external drainage and depression device. The remaining authors have no other conflicts of interest to disclose. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|